Shuqing Lü

The resistance mechanisms of proteasome inhibitor bortezomib

Shuqing Lü, Jianmin Wang · Biomarker Research · 2013 · 159 citations · Full text

Medicine, Oncology, Pharmacology +17

Point Mutation of the Proteasome β5 Subunit Gene Is an Important Mechanism of Bortezomib Resistance in Bortezomib-Selected Variants of Jurkat T Cell Lymphoblastic Lymphoma/Leukemia Line

Shuqing Lü, Jianmin Yang, Xianmin Song et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 107 citations

Medicine, Molecular Biology, Pharmacology +15

Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/leukemia cells derived from Jurkat line

Shuqing Lü, Zhilong Chen, Jianmin Yang et al. · Experimental Hematology · 2008 · 89 citations

Medicine, Molecular Biology, Oncology +14

Different mutants of PSMB5 confer varying bortezomib resistance in T lymphoblastic lymphoma/leukemia cells derived from the Jurkat cell line

Shuqing Lü, Jianmin Yang, Zhilong Chen et al. · Experimental Hematology · 2009 · 84 citations

Medicine, Molecular Biology, Oncology +14

A homoharringtonine-based induction regimen for the treatment of elderly patients with acute myeloid leukemia: a single center experience from China

Jianmin Wang, Shuqing Lü, Jianmin Yang et al. · Journal of Hematology & Oncology · 2009 · 36 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16